Paper40718751
Micro-costing analysis from Italian Guidelines for the management of sporadic primary hyperparathyroidism.
Ilaria V and 44 others. Glob Reg Health Technol Assess, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Micro-costing analysis from Italian Guidelines for the management of sporadic primary hyperparathyroidism. Papers, record 40718751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40718751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Micro-costing analysis from Italian Guidelines for the management of sporadic primary hyperparathyroidism.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17350965 | Parenting programme for parents of children at risk of developing conduct disorder: cost effectiveness analysis. | BMJ | 2007 | https://conductscience.org/library/papers/17350965 | PubMed |
| 2 | 30665546 | Genetics of parathyroids disorders: Overview. | Best Pract Res Clin Endocrinol Metab | 2018 | https://conductscience.org/library/papers/30665546 | PubMed |
| 3 | 32621588 | Cinacalcet and primary hyperparathyroidism: systematic review and meta regression. | Endocr Connect | 2020 | https://conductscience.org/library/papers/32621588 | PubMed |
| 4 | 34863037 | European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders. | Eur J Endocrinol | 2022 | https://conductscience.org/library/papers/34863037 | PubMed |
| 5 | 34842909 | Risk of Fracture Among Older Adults With Primary Hyperparathyroidism Receiving Parathyroidectomy vs Nonoperative Management. | JAMA Intern Med | 2022 | https://conductscience.org/library/papers/34842909 | PubMed |
| 6 | 12838336 | Extracellular calcium sensing and signalling. | Nat Rev Mol Cell Biol | 2003 | https://conductscience.org/library/papers/12838336 | PubMed |
| 7 | 26985167 | Primary hyperparathyroidism. | Ulus Cerrahi Derg | 2016 | https://conductscience.org/library/papers/26985167 | PubMed |
| 8 | 36245251 | Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. | J Bone Miner Res | 2022 | https://conductscience.org/library/papers/36245251 | PubMed |
| 9 | 32333877 | Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial. | Lancet Diabetes Endocrinol | 2020 | https://conductscience.org/library/papers/32333877 | PubMed |
| 10 | 11149474 | Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. | J Bone Miner Res | 2001 | https://conductscience.org/library/papers/11149474 | PubMed |
| 11 | 24497214 | Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB). | J Endocrinol Invest | 2014 | https://conductscience.org/library/papers/24497214 | PubMed |
| 12 | 39820817 | How has the diagnostic approach to parathyroid localization techniques evolved in the past decade? Insights from a single-center experience. | Updates Surg | 2025 | https://conductscience.org/library/papers/39820817 | PubMed |
| 13 | 28885621 | Primary hyperparathyroidism. | Nat Rev Endocrinol | 2018 | https://conductscience.org/library/papers/28885621 | PubMed |
| 14 | 25820553 | Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. | J Endocrinol Invest | 2015 | https://conductscience.org/library/papers/25820553 | PubMed |
| 15 | 34991581 | The effect of parathyroidectomy compared to non-surgical surveillance on kidney function in primary hyperparathyroidism: a nationwide historic cohort study. | BMC Endocr Disord | 2022 | https://conductscience.org/library/papers/34991581 | PubMed |
| 16 | 21158894 | A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). | Clin Endocrinol (Oxf) | 2011 | https://conductscience.org/library/papers/21158894 | PubMed |
| 17 | 10977834 | Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. | BMJ | 2000 | https://conductscience.org/library/papers/10977834 | PubMed |
| 18 | 28712071 | Ultrasound detection of normal parathyroid glands: a preliminary study. | Radiol Med | 2017 | https://conductscience.org/library/papers/28712071 | PubMed |
| 19 | 36054175 | Surgical Aspects of Primary Hyperparathyroidism. | J Bone Miner Res | 2022 | https://conductscience.org/library/papers/36054175 | PubMed |
| 20 | 36053960 | The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | J Bone Miner Res | 2022 | https://conductscience.org/library/papers/36053960 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40718751
GET https://conductscience.org/api/papers/v1/40718751/authors?page=2